GENERIC IMATINIB VS GLEEVEC

Código QR

GENERIC IMATINIB VS GLEEVEC

Guardado en:

Detalles Bibliográficos
Autor principal:	Katia Borgia Barbosa Pagnano
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/de67607d56cc435281a4dcb48c05cd57
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
por: Waclaw J, et al.
Publicado: (2015)

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
por: Natalia Estrada, et al.
Publicado: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
por: Shoumariyeh K, et al.
Publicado: (2014)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

PP Transcon 2020 Abstracts Compilation
Publicado: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
por: Rasika D Setia, et al.
Publicado: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
por: Anand Deshpande, et al.
Publicado: (2021)

Oration - Dr Sanmukh Joshi
Publicado: (2021)

OP Transcon 2020 Abstracts Compilation
Publicado: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publicado: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
por: Vijeta Bajpai, et al.
Publicado: (2021)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
por: Samuel sarmiento Doncel, et al.
Publicado: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
por: Brian Eyden, et al.
Publicado: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
por: Ming Hou
Publicado: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
por: Hooriyeh Shapoorian, et al.
Publicado: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
por: Yaxin Zheng, et al.
Publicado: (2021)

Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
por: Shanshan Zhang, et al.
Publicado: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Meletios A. Dimopoulos, et al.
Publicado: (2021)

De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment
por: Despina Fotiou, et al.
Publicado: (2021)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
por: Achille Iolascon, et al.
Publicado: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Julio Delgado, et al.
Publicado: (2021)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hans C. Hasselbalch, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
por: Colin Vercueil, et al.
Publicado: (2021)

Azacytidine Treatment for VEXAS Syndrome
por: Marc H. G. P. Raaijmakers, et al.
Publicado: (2021)

tiRNA Join Hematopoietic Niches
por: Melania Tesio
Publicado: (2021)

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience
por: Anne Sophie Alary, et al.
Publicado: (2021)

The EHA Research Roadmap: Normal Hematopoiesis
por: Thierry Jaffredo, et al.
Publicado: (2021)

HSP70 and FLT3-ITD: Targeting chaperone system to overcome drug resistance
por: Jing Yang, et al.
Publicado: (2021)

Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application
por: Li-Min Lin, et al.
Publicado: (2021)

The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil
por: Dante Mário Langhi Junior, et al.
Publicado: (2021)

Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate-DVI) Concentrate and its Low-Dose Use
por: Dagmar M. Hajducek, et al.
Publicado: (2021)

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
por: Rory M. Shallis, et al.
Publicado: (2021)

External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
por: Pierre Chelle, et al.
Publicado: (2021)

Falsely positive heparin‐induced thrombocytopenia antibody testing in severe hyperbilirubinemia
por: Daniel Egert, et al.
Publicado: (2021)

A Rare Cause of Acquired Factor X Deficiency in an 87-Year-Old Female
por: Ayrton Bangolo, et al.
Publicado: (2021)

Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism
por: Wardah Aslam, et al.
Publicado: (2021)

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
por: Foteini Theodorakakou, et al.
Publicado: (2021)